- Home
- COR
COR
Cencora Inc.
as 05-20-2024 4:00pm EST
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | CONSHOHOCKEN |
| Market Cap: | 44.2B | IPO Year: | N/A |
| Target Price: | $249.50 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | 0.92% | Dividend Payout Frequency: | Quarterly |
| EPS: | 9.15 | EPS Growth: | 17.46 |
| 52 Week Low/High: | $163.37 - $246.75 | Next Earning Date: | 05-01-2024 |
| Revenue: | $276,536,514,000 | Revenue Growth: | 11.71% |
| Revenue Growth (this year): | 12.47% | Revenue Growth (next year): | 6.38% |
Share on Social Networks:
Stock Insider Trading Activity of Cencora Inc. (COR)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| COLLIS STEVEN H | COR | Chairman, President & CEO | Apr 16 '24 | Sell | $237.48 | 10,754 | $2,553,859.92 | 285,088 | SEC Form 4 |
| Mauch Robert P. | COR | Executive Vice President & COO | Apr 15 '24 | Sell | $235.09 | 57,564 | $13,532,720.76 | 24,412 | SEC Form 4 |
| Clark Gina | COR | Executive Vice President | Feb 13 '24 | Sell | $230.48 | 1,100 | $253,528.00 | 24,802 | SEC Form 4 |
| COLLIS STEVEN H | COR | Chairman, President & CEO | Dec 12 '23 | Sell | $202.15 | 25,000 | $5,053,750.00 | 331,573 | SEC Form 4 |
| Krikorian Lazarus | COR | SVP & Chief Accounting Officer | Dec 1 '23 | Sell | $203.60 | 2,000 | $407,204.00 | 19,876 | SEC Form 4 |
| COLLIS STEVEN H | COR | Chairman, President & CEO | Nov 14 '23 | Sell | $197.63 | 25,000 | $4,940,750.00 | 331,573 | SEC Form 4 |
Latest Cencora Inc. News
COR Breaking Stock News: Dive into COR Ticker-Specific Updates for Smart Investing
Simply Wall St.
16 days ago
There's A Lot To Like About Cencora's (NYSE:COR) Upcoming US$0.51 Dividend
Zacks
18 days ago
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Simply Wall St.
18 days ago
Cencora Second Quarter 2024 Earnings: Misses Expectations
Morningstar Research
19 days ago
Analyst Report: Cencora, Inc.
Business Wire
19 days ago
Cencora Reports Fiscal 2024 Second Quarter Results
Zacks
a month ago
Here's Why Cencora (COR) is a Strong Value Stock
Zacks
a month ago
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Business Wire
a month ago